Leavey awarded NIH R21 grant

Patrick Leavey, M.D.,Associate Vice Chair of Research Operations and Professor of Pediatrics, has been selected to receive an exploratory/developmental (R21) grant from the National Institutes of Health (NIH). The grant provides funding and protected time towards the development of new research activities in categorical program areas.

Led by Dr. Leavey, the funded study seeks to improve risk assessment for patients with Ewing sarcoma, a rare and aggressive pediatric bone and soft-tissue cancer. Using artificial intelligence to analyze digital pathology images and identify patterns that may predict which patients are at higher risk for poor outcomes, the study's findings could lead to more personalized treatment strategies, improving survival rates and quality of life for children and adolescents facing this disease.